{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T16:34:04Z","timestamp":1794674044371,"version":"4.9.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,21]],"date-time":"2025-07-21T00:00:00Z","timestamp":1753056000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,21]],"date-time":"2025-07-21T00:00:00Z","timestamp":1753056000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>The study of the trigeminal autonomic cephalalgias (TAC) has been limited by difficulty aggregating sufficient numbers of patients. We used the Epic Cosmos electronic health record research platform to harness nationwide data from health care systems across the United States using the Epic electronic health record to analyze the prevalence, demographics, comorbid conditions and treatments for the TACs.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>We queried the Epic Cosmos electronic health record database for patients with diagnoses of hemicrania continua, cluster headache, paroxysmal hemicrania, and SUNCT. Prevalences, demographics were determined from this database and comorbid conditions and treatments for these conditions were analyzed.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Our study included 152,727 patients with cluster headache, 59,312 patients with paroxysmal hemicrania, 19,321 patients with hemicrania continua, and 6,291 patients with SUNCT. Five-year prevalence of cluster headache was highest (56.7 per 100,000), followed by paroxysmal hemicrania (22.0 per 100,000), hemicrania continua (7.2 per 100,000) and SUNCT (2.3 per 100,000). All four TACs showed a higher prevalence in women. Migraine was common in all four conditions and patients with cluster headache had the highest rates of nicotine, alcohol, and cannabis use disorders. Indomethacin was notably underutilized for the indomethacin-responsive TACs.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>We use a national electronic medical record database to give insight into elements of the TACs that have been previously limited by the relative rarity of these diseases.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s12883-025-04314-1","type":"journal-article","created":{"date-parts":[[2025,7,21]],"date-time":"2025-07-21T05:29:58Z","timestamp":1753075798000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Prevalence, demographics, comorbidities, and treatment patterns of patients with the trigeminal autonomic cephalalgias: a retrospective analysis of United States electronic health records"],"prefix":"10.1186","volume":"25","author":[{"given":"Leon S.","family":"Moskatel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oyindamola","family":"Ogunlaja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niushen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,21]]},"reference":[{"key":"4314_CR1","doi-asserted-by":"publisher","first-page":"251581632210755","DOI":"10.1177\/25158163221075569","volume":"5","author":"J Crespi","year":"2022","unstructured":"Crespi J, Gulati S, Salvesen \u00d8, et al. Epidemiology of diagnosed cluster headache in Norway. Cephalagia. 2022;5:25158163221075569.","journal-title":"Cephalagia"},{"issue":"9","key":"4314_CR2","doi-asserted-by":"publisher","first-page":"033310242312015","DOI":"10.1177\/03331024231201577","volume":"43","author":"SA Kim","year":"2023","unstructured":"Kim SA, Choi SY, Youn MS, Pozo-Rosich P, Lee MJ. Epidemiology, burden and clinical spectrum of cluster headache: a global update. Cephalalgia. 2023;43(9):03331024231201577.","journal-title":"Cephalalgia"},{"issue":"1","key":"4314_CR3","doi-asserted-by":"publisher","first-page":"033310242211313","DOI":"10.1177\/03331024221131343","volume":"43","author":"HM Al-Khazali","year":"2023","unstructured":"Al-Khazali HM, Al-Khazali S, Iljazi A, Christensen RH, Ashina S, Lipton RB, Amin FM, Ashina H. Prevalence and clinical features of hemicrania continua in clinic-based studies: A systematic review and meta-analysis. Cephalalgia. 2023;43(1):03331024221131343.","journal-title":"Cephalalgia"},{"issue":"1","key":"4314_CR4","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/head.14658","volume":"64","author":"MJ Henningsen","year":"2024","unstructured":"Henningsen MJ, Larsen JG, Karlsson WK, Christensen RH, Al-Khazali HM, Amin FM, Ashina H. Epidemiology and clinical features of paroxysmal hemicrania: A systematic review and meta\u2010analysis. Headache: J Head Face Pain. 2024;64(1):5\u201315.","journal-title":"Headache: J Head Face Pain"},{"issue":"1","key":"4314_CR5","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s10194-024-01738-x","volume":"25","author":"K Hagen","year":"2024","unstructured":"Hagen K. One-year prevalence of cluster headache, hemicrania continua, paroxysmal hemicrania and SUNCT in norway: a population-based nationwide registry study. J Headache Pain. 2024;25(1):30.","journal-title":"J Headache Pain"},{"issue":"5","key":"4314_CR6","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.4103\/aian.AIAN_349_17","volume":"21","author":"DYT Wei","year":"2018","unstructured":"Wei DYT, Yuan Ong JJ, Goadsby PJ. Cluster headache: epidemiology, pathophysiology, clinical features, and diagnosis. Ann Indian Acad Neurol. 2018;21(5):S3\u20138. https:\/\/doi.org\/10.4103\/aian.AIAN_349_17.","journal-title":"Ann Indian Acad Neurol"},{"issue":"4","key":"4314_CR7","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1212\/CON.0000000000000625","volume":"24","author":"M Burish","year":"2018","unstructured":"Burish M. Cluster headache and other trigeminal autonomic cephalalgias. Continuum: Lifelong Learn Neurol. 2018;24(4):1137\u201356.","journal-title":"Continuum: Lifelong Learn Neurol"},{"issue":"7","key":"4314_CR8","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1111\/head.12866","volume":"56","author":"MS Robbins","year":"2016","unstructured":"Robbins MS, Starling AJ, Pringsheim TM, Becker WJ, Schwedt TJ. Treatment of cluster headache: the American headache society evidence-based guidelines. Headache: J Head Face Pain. 2016;56(7):1093\u2013106.","journal-title":"Headache: J Head Face Pain"},{"key":"4314_CR9","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1007\/s40265-018-1002-7","volume":"78","author":"YN Lamb","year":"2018","unstructured":"Lamb YN. Galcanezumab: first global approval. Drugs. 2018;78:1769\u201375.","journal-title":"Drugs"},{"key":"4314_CR10","unstructured":"3.4 hemicrania continua. 2018. Available from: https:\/\/ichd-3.org\/3-trigeminal-autonomic-cephalalgias\/3-4-hemicrania-continua\/. Cited 2024 Sept 26."},{"issue":"10","key":"4314_CR11","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1007\/s11916-023-01156-9","volume":"27","author":"HM Al-Khazali","year":"2023","unstructured":"Al-Khazali HM, Christensen RH, Lambru G, Dodick DW, Ashina H. Hemicrania continua: an update. Curr Pain Headache Rep. 2023;27(10):543\u201350.","journal-title":"Curr Pain Headache Rep"},{"issue":"2","key":"4314_CR12","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1212\/CON.0000000000001409","volume":"30","author":"PJ Goadsby","year":"2024","unstructured":"Goadsby PJ. Indomethacin-responsive headache disorders. CONTINUUM: Lifelong Learn Neurol. 2024;30(2):488\u201397.","journal-title":"CONTINUUM: Lifelong Learn Neurol"},{"issue":"8","key":"4314_CR13","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1007\/s11916-015-0511-2","volume":"19","author":"JL Pomeroy","year":"2015","unstructured":"Pomeroy JL, Nahas SJ. SUNCT\/SUNA: a review. Curr Pain Headache Rep. 2015;19(8):38. https:\/\/doi.org\/10.1007\/s11916-015-0511-2.","journal-title":"Curr Pain Headache Rep"},{"issue":"1","key":"4314_CR14","doi-asserted-by":"publisher","first-page":"e36","DOI":"10.1055\/s-0041-1731004","volume":"5","author":"Y Tarabichi","year":"2021","unstructured":"Tarabichi Y, Frees A, Honeywell S, et al. The Cosmos collaborative: A Vendor-Facilitated electronic health record data aggregation platform. ACI Open. 2021;5(1):e36\u201346. https:\/\/doi.org\/10.1055\/s-0041-1731004.","journal-title":"ACI Open"},{"key":"4314_CR15","unstructured":"About. Epic Cosmos. Available from: https:\/\/cosmos.epic.com\/about\/. Cited 2024 Sept 6."},{"key":"4314_CR16","doi-asserted-by":"publisher","first-page":"1530499","DOI":"10.3389\/fneur.2025.1530499","volume":"16","author":"LS Moskatel","year":"2025","unstructured":"Moskatel LS, Linfield RY, Zhang N. The impact of headache specialist density and the introduction of gepants and Lasmitidan on prescriptions for acute migraine treatments: a regression and interrupted time series analysis. Front Neurol. 2025;16:1530499.","journal-title":"Front Neurol"},{"issue":"6","key":"4314_CR17","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1111\/j.1468-2982.2008.01592.x","volume":"28","author":"M Fischera","year":"2008","unstructured":"Fischera M, Marziniak M, Gralow I, Evers S. The incidence and prevalence of cluster headache: a meta-analysis of population-based studies. Cephalalgia. 2008;28(6):614\u20138.","journal-title":"Cephalalgia"},{"issue":"1","key":"4314_CR18","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s10194-006-0292-4","volume":"8","author":"O Sjaastad","year":"2007","unstructured":"Sjaastad O, Bakketeig LS. The rare, unilateral headaches. V\u00e5g\u00e5 study of headache epidemiology. J Headache Pain. 2007;8(1):19\u201327.","journal-title":"J Headache Pain"},{"issue":"7","key":"4314_CR19","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1046\/j.1468-2982.2003.00585.x","volume":"23","author":"O Sjaastad","year":"2003","unstructured":"Sjaastad O, Bakketeig LS. Cluster headache prevalence. V\u00e5g\u00e5 study of headache epidemiology. Cephalalgia. 2003;23(7):528\u201333.","journal-title":"Cephalalgia"},{"key":"4314_CR20","unstructured":"Lunde ESRJ, Syse A, Kvinners liv og helse siste 20 \u00e5r.: Statistics Norway. 2022. Available from: https:\/\/www.ssb.no\/helse\/helsetjenester\/artikler\/kvinners-liv-og-helse-siste-20-ar\/_\/attachment\/inline\/c631d917-23e0-4f6d-aeaf-adc41747c6dc:f888278b9158f6df00294ec20c1441dbe7baf661\/RAPP2022-41.pdf."},{"issue":"3","key":"4314_CR21","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1046\/j.1468-2982.1998.1803138.x","volume":"18","author":"GC Manzoni","year":"1998","unstructured":"Manzoni GC. Gender ratio of cluster headache over the years: a possible role of changes in lifestyle. Cephalalgia. 1998;18(3):138\u201342.","journal-title":"Cephalalgia"},{"issue":"4","key":"4314_CR22","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1002\/ana.26743","volume":"94","author":"BS Winsvold","year":"2023","unstructured":"Winsvold BS, Harder AVE, Ran C, Chalmer MA, Dalmasso MC, Ferkingstad E, et al. Cluster headache genomewide association study and Meta-Analysis identifies eight loci and implicates smoking as causal risk factor. Ann Neurol. 2023;94(4):713\u201326.","journal-title":"Ann Neurol"},{"key":"4314_CR23","unstructured":"Current Cigarette Smoking Among Adults in the United States. Available from: https:\/\/www.cdc.gov\/tobacco\/data_statistics\/fact_sheets\/adult_data\/cig_smoking\/index.htm."},{"issue":"10","key":"4314_CR24","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1111\/j.1526-4610.1989.hed2910648.x","volume":"29","author":"F Antonaci","year":"1989","unstructured":"Antonaci F, Sjaastad O. Chronic paroxysmal hemicrania (CPH): a review of the clinical manifestations. Headache. 1989;29(10):648\u201356.","journal-title":"Headache"},{"issue":"8","key":"4314_CR25","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1046\/j.1526-4610.2002.02171.x","volume":"42","author":"CJ Boes","year":"2002","unstructured":"Boes CJ, Dodick DW. Refining the clinical spectrum of chronic paroxysmal hemicrania: a review of 74 patients. Headache. 2002;42(8):699\u2013708.","journal-title":"Headache"},{"issue":"4","key":"4314_CR26","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1093\/brain\/awn010","volume":"131","author":"E Cittadini","year":"2008","unstructured":"Cittadini E, Matharu MS, Goadsby PJ. Paroxysmal hemicrania: a prospective clinical study of 31 cases. Brain. 2008;131(4):1142\u201355.","journal-title":"Brain"},{"issue":"1","key":"4314_CR27","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/head.14658","volume":"64","author":"MJ Henningsen","year":"2024","unstructured":"Henningsen MJ, Larsen JG, Karlsson WK, Christensen RH, Al-Khazali HM, Amin FM, et al. Epidemiology and clinical features of paroxysmal hemicrania: A systematic review and meta-analysis. Headache. 2024;64(1):5\u201315.","journal-title":"Headache"},{"issue":"12","key":"4314_CR28","doi-asserted-by":"publisher","first-page":"e1127","DOI":"10.1212\/WNL.0000000000008134","volume":"93","author":"G Lambru","year":"2019","unstructured":"Lambru G, Rantell K, Levy A, Matharu MS. A prospective comparative study and analysis of predictors of SUNA and SUNCT. Neurology. 2019;93(12):e1127\u201337.","journal-title":"Neurology"},{"issue":"9","key":"4314_CR29","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1046\/j.1468-2982.2001.00280.x","volume":"21","author":"D Dodick","year":"2001","unstructured":"Dodick D. Hemicrania continua: diagnostic criteria and nosologic status. Cephalalgia. 2001;21(9):869\u201372.","journal-title":"Cephalalgia"},{"issue":"6","key":"4314_CR30","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1046\/j.1526-4610.1996.3606379.x","volume":"36","author":"EE Alders","year":"1996","unstructured":"Alders EE, Hentzen A, Tan CT. A community-based prevalence study on headache in Malaysia. Headache. 1996;36(6):379\u201384.","journal-title":"Headache"},{"issue":"1","key":"4314_CR31","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s12883-023-03122-9","volume":"23","author":"K Hirata","year":"2023","unstructured":"Hirata K, Sano H, Kondo H, Shibasaki Y, Koga N. Clinical characteristics, medication use, and impact of primary headache on daily activities: an observational study using linked online survey and medical claims data in Japan. BMC Neurol. 2023;23(1):80.","journal-title":"BMC Neurol"},{"issue":"9","key":"4314_CR32","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1177\/0333102413520083","volume":"34","author":"YJ Lee","year":"2014","unstructured":"Lee YJ, Chen YT, Ou SM, Li SY, Yang AC, Tang CH, et al. Temperature variation and the incidence of cluster headache periods: A nationwide population study. Cephalalgia. 2014;34(9):656\u201363.","journal-title":"Cephalalgia"},{"issue":"6","key":"4314_CR33","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1212\/WNL.57.6.948","volume":"57","author":"MF Peres","year":"2001","unstructured":"Peres MF, Silberstein SD, Nahmias S, Shechter AL, Youssef I, Rozen TD, et al. Hemicrania continua is not that rare. Neurology. 2001;57(6):948\u201351.","journal-title":"Neurology"},{"issue":"1","key":"4314_CR34","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s10194-021-01281-z","volume":"22","author":"V Caponnetto","year":"2021","unstructured":"Caponnetto V, Deodato M, Robotti M, Koutsokera M, Pozzilli V, Galati C, et al. Comorbidities of primary headache disorders: a literature review with meta-analysis. J Headache Pain. 2021;22(1):71.","journal-title":"J Headache Pain"},{"issue":"1","key":"4314_CR35","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1111\/j.1526-4610.2011.02028.x","volume":"52","author":"TD Rozen","year":"2012","unstructured":"Rozen TD, Fishman RS. Cluster headache in the united States of america: demographics, clinical characteristics, triggers, suicidality, and personal burden. Headache. 2012;52(1):99\u2013113.","journal-title":"Headache"},{"issue":"10","key":"4314_CR36","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1177\/0333102419845660","volume":"39","author":"M Ji Lee","year":"2019","unstructured":"Ji Lee M, Cho SJ, Wook Park J, Kyung Chu M, Moon HS, Chung PW, et al. Increased suicidality in patients with cluster headache. Cephalalgia. 2019;39(10):1249\u201356.","journal-title":"Cephalalgia"},{"issue":"2","key":"4314_CR37","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1046\/j.1468-2982.1999.019002088.x","volume":"19","author":"GC Manzoni","year":"1999","unstructured":"Manzoni GC. Cluster headache and lifestyle: remarks on a population of 374 male patients. Cephalalgia. 1999;19(2):88\u201394.","journal-title":"Cephalalgia"},{"issue":"5","key":"4314_CR38","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1111\/head.13295","volume":"58","author":"TD Rozen","year":"2018","unstructured":"Rozen TD. Cluster headache clinical phenotypes: tobacco nonexposed (Never smoker and no parental secondary smoke exposure as a Child) versus tobacco-Exposed: results from the united States cluster headache survey. Headache. 2018;58(5):688\u201399.","journal-title":"Headache"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-025-04314-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12883-025-04314-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-025-04314-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T16:00:00Z","timestamp":1757260800000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/s12883-025-04314-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,21]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4314"],"URL":"https:\/\/doi.org\/10.1186\/s12883-025-04314-1","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,21]]},"assertion":[{"value":"9 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This project was exempted from Institutional Review Board Review as it did not meet the criteria for Stanford University\u2019s definition of Human Subject research requiring IRB approval per OHRP 45 CFR 46.102.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"OO and NZ declare no financial conflicts of interest. LSM is a site investigator for a clinical trial sponsored by Rehaler.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"299"}}